FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.706
-0.067 (-8.61%)
At close: Feb 21, 2025, 4:00 PM
0.658
-0.048 (-6.80%)
After-hours: Feb 21, 2025, 7:59 PM EST
FibroGen Market Cap
FibroGen has a market cap or net worth of $71.13 million as of February 21, 2025. Its market cap has decreased by -62.12% in one year.
Market Cap
71.13M
Enterprise Value
33.11M
1-Year Change
-62.12%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $71.13M, a decrease of -94.19%. That is a compound annual growth rate of -24.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 71.10M | 33.40% |
| Dec 31, 2024 | 53.30M | -38.81% |
| Dec 29, 2023 | 87.10M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |